Curable acrylate compositions, methods of making the compositions and articles made therefrom

Details for Australian Patent Application No. 2006220699 (hide)

Owner General Electric Company

Inventors Chisholm, Bret Ja; Huntley, Christian Andrew; Smigelski, Jr. Paul michael; Chen, Alvin Un-Teh; Olson, Daniel Robert; Coyle, Dennis Joseph

Agent Davies Collison Cave

Pub. Number AU-A-2006220699

PCT Pub. Number WO2006/096643

Priority 11/074,272 07.03.05 US

Filing date 6 March 2006

Wipo publication date 14 September 2006

International Classifications

C09D 133/00 (2006.01) Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/096643 Priority application(s): WO2006/096643

19 June 2008 Assignment before Grant

  General Electric Company The application has been assigned to SABIC Innovative Plastics IP B.V.

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220708-Process for preparing macrocyclic compounds

2006220696-Use of neuronal precursor cells for treatment of central nervous system lesions